The Facts

  • Breast cancer is the second most common cancer in the UK after non-melanoma skin cancer and over 44,100 new cases are diagnosed every year
  • Breast cancer claims the lives of 12,500 women each year in the UK. Men can also get breast cancer but it is rare (around 335 cases are diagnosed each year)
  • Of those women diagnosed with breast cancer today, two-thirds are likely to survive for at least 20 years
  • For more information please visit http://www.breastcancercare.org.uk/

Our Money

  • It is hoped that the money raised by Richmond Pharmacology will help to improve the survival rates of women with breast cancer for years to come
  • Richmond Pharmacology Ltd is pleased to have raised over �120 for breast cancer
Some of the Richmond Team
Some of the Richmond Team

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event